Adjuvant treatment and recurrences
| Adjuvant treatment or recurrence status | Overall cohort (n=100) | Parametrial involvement (n=10) | No parametrial involvement (n=90) | P value |
| Adjuvant treatment* | 0.11 | |||
| Chemo+RT | 47 (48) | 6 (60) | 41 (46) | |
| Chemo | 26 (26) | 0 (0) | 26 (29) | |
| RT | 16 (16) | 2 (20) | 14 (16) | |
| None | 10 (11) | 2 (20) | 9 (10) | |
| Recurrence† | 0.1 | |||
| No | 46/98 (46) | 2/10 (20) | 44/88 (51) | |
| Yes | 51/98 (51) | 8/10 (80) | 43/88 (48) | |
| Location of recurrence‡ | 0.72 | |||
| Distant | 23/40 (58) | 4/7 (57) | 19/33 (58) | |
| Local | 10/40 (25) | 1/7 (14) | 9/33 (27) | |
| Both distant+local | 7/40 (18) | 2/7 (29) | 5/33 (15) |
*One patient was lost to follow-up with unknown adjuvant treatment status.
†Information about recurrence was available for 98 of the 100 patients. One patient died of the disease without recurrence.
‡Location of recurrence was available for 40 of the 50 patients with recurrence.
Chemo, chemotherapy; RT, radiotherapy.